AOTCX
Price
$29.19
Change
-$0.03 (-0.10%)
Updated
Jan 29 closing price
Net Assets
161.97M
VEMIX
Price
$27.91
Change
+$0.05 (+0.18%)
Updated
Jan 29 closing price
Net Assets
108.96B
Ad is loading...

AOTCX vs VEMIX

Header iconAOTCX vs VEMIX Comparison
Open Charts AOTCX vs VEMIXBanner chart's image
Virtus Emerging Markets Opps C
Price$29.19
Change-$0.03 (-0.10%)
VolumeN/A
Net Assets161.97M
Vanguard Emerging Mkts Stock Idx Instl
Price$27.91
Change+$0.05 (+0.18%)
VolumeN/A
Net Assets108.96B
AOTCX vs VEMIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AOTCX vs. VEMIX commentary
Jan 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AOTCX is a Buy and VEMIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEMIX has more cash in the bank: 109B vs. AOTCX (162M). VEMIX pays higher dividends than AOTCX: VEMIX (3.46) vs AOTCX (1.92). AOTCX was incepted earlier than VEMIX: AOTCX (18 years) vs VEMIX (25 years). AOTCX is a more actively managed with annual turnover of: 109.00 vs. VEMIX (5.00). AOTCX has a lower initial minimum investment than VEMIX: AOTCX (2500) vs VEMIX (5000000). VEMIX annual gain was more profitable for investors over the last year : 13.46 vs. AOTCX (7.76). AOTCX return over 5 years is better than : 17.82 vs. VEMIX (15.58).
AOTCXVEMIXAOTCX / VEMIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence18 years25 years-
Gain YTD1.038-0.179-581%
Front LoadN/AN/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets162M109B0%
Annual Yield % from dividends1.923.4655%
Returns for 1 year7.7613.4658%
Returns for 3 years-2.64-1.56170%
Returns for 5 years17.8215.58114%
Returns for 10 years25.7530.5384%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BSGM0.950.03
+3.36%
BioSig Technologies, Inc.
CNF1.230.04
+3.36%
CNFinance Holdings Limited
EWTX28.420.62
+2.23%
Edgewise Therapeutics
MERC6.680.13
+1.98%
Mercer International
RDY13.52-0.01
-0.07%
Dr. Reddy's Laboratories Ltd